Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
29 May 2025$SBET exploded +171.6% to $79.21 after announcing a massive $425M private placement with Ethereum integration. The deal puts the company squarely in the crypto sports betting spotlight. Volume ripped past 18M, signaling major momentum.
$STRM surged +126.2% to $5.18 after confirming its merger with MDaudit. The combined company aims to lead healthcare compliance automation. Volume spiked from a mere 7K average to over 2.9M, drawing serious trader attention.
$ALZN popped +63.9% to $5.44 after dosing the first patient in its Phase II Alzheimer trial. Traders piled in on hopes for neuro success, with volume skyrocketing to 77M—nearly 100x the daily norm.
$HTCR rallied +26.8% to $0.74, riding the AI wave after Nvidia blowout quarter. Volume topped 37M, far above the usual flow. Traders are betting HTCR has AI tailwinds in its future.
$IINN jumped +25.6% to $0.54 after highlighting its FDA-cleared ART100 system and upcoming discussions with government health ministries. Volume swelled to 10M, signaling strong speculative interest.
$INTS climbed +24% to $0.39 as excitement builds over its sarcoma trial data to be presented at ASCO 2025. The event is still months away, but early buyers are positioning ahead of the buzz.
$SVT moved up +23.2% to $46.65 after TransDigm raised its acquisition offer to $47/share. Traders hunting M&A premiums see limited downside and solid upside if another bid comes in.
$VEEV soared +19% to $279.04 after crushing earnings: $1.97 EPS vs. $1.77 est, with 17% YoY revenue growth. It broke above key resistance at $275, and analysts are now setting sights on $300+.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
